Lineage-defined leiomyosarcoma subtypes emerge years before diagnosis and determine patient survival

Leiomyosarcomas (LMS) are genetically heterogeneous tumors differentiating along smooth muscle lines. Currently, LMS treatment is not informed by molecular subtyping and is associated with highly variable survival. While disease site continues to dictate clinical management, the contribution of gene...

Descripción completa

Detalles Bibliográficos
Autores principales: Anderson, Nathaniel D., Babichev, Yael, Fuligni, Fabio, Comitani, Federico, Layeghifard, Mehdi, Venier, Rosemarie E., Dentro, Stefan C., Maheshwari, Anant, Guram, Sheena, Wunker, Claire, Thompson, J. Drew, Yuki, Kyoko E., Hou, Huayun, Zatzman, Matthew, Light, Nicholas, Bernardini, Marcus Q., Wunder, Jay S., Andrulis, Irene L., Ferguson, Peter, Razak, Albiruni R. Abdul, Swallow, Carol J., Dowling, James J., Al-Awar, Rima S., Marcellus, Richard, Rouzbahman, Marjan, Gerstung, Moritz, Durocher, Daniel, Alexandrov, Ludmil B., Dickson, Brendan C., Gladdy, Rebecca A., Shlien, Adam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8302638/
https://www.ncbi.nlm.nih.gov/pubmed/34301934
http://dx.doi.org/10.1038/s41467-021-24677-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8302638/
https://www.ncbi.nlm.nih.gov/pubmed/34301934
http://dx.doi.org/10.1038/s41467-021-24677-6

Ejemplares similares